Skip to main content
. 2020 Sep 15;100(12):2186–2197. doi: 10.1093/ptj/pzaa162

Table 1.

Demographic and Treatment-Related Data (N = 647)a

Patient Variable n %
Age at diagnosis (range: 27–83, mean 56.6 y) <50 y 188 29.1%
50–69 y 405 62.6%
≥ 70 y 54 8.3%
Breast surgery Mastectomy 150 23.2%
Lumpectomy 497 76.8%
Chemotherapy Neoadjuvant chemo 18 2.8%
Adjuvant chemo 200 30.9%
No chemo 429 66.3%
Body mass index (range 16.1–58.9, mean 27.7) BMI ≥ 25 399 61.7%
BMI < 25 248 38.3%
Axillary surgery ALND 120 18.6%
SLNB 461 71.3%
No axillary surgery 66 10.2%
Regional lymph node radiation RLNR 151 23.3%
No RLNR 496 76.7%

a BMI = body mass index; ALND = axillary lymph node dissection; SLNB = sentinel lymph node biopsy; RLNR = regional lymph node radiation.